Charles Schwab’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $603K | Buy |
157,538
+19,553
| +14% | +$74.9K | ﹤0.01% | 3076 |
|
2025
Q1 | $793K | Buy |
137,985
+1,252
| +0.9% | +$7.2K | ﹤0.01% | 2923 |
|
2024
Q4 | $682K | Hold |
136,733
| – | – | ﹤0.01% | 3047 |
|
2024
Q3 | $737K | Hold |
136,733
| – | – | ﹤0.01% | 3018 |
|
2024
Q2 | $453K | Buy |
136,733
+11,208
| +9% | +$37.1K | ﹤0.01% | 3240 |
|
2024
Q1 | $410K | Hold |
125,525
| – | – | ﹤0.01% | 3098 |
|
2023
Q4 | $441K | Hold |
125,525
| – | – | ﹤0.01% | 3122 |
|
2023
Q3 | $839K | Hold |
125,525
| – | – | ﹤0.01% | 2859 |
|
2023
Q2 | $1.05M | Buy |
125,525
+103,324
| +465% | +$867K | ﹤0.01% | 2755 |
|
2023
Q1 | $220K | Hold |
22,201
| – | – | ﹤0.01% | 3136 |
|
2022
Q4 | $155K | Hold |
22,201
| – | – | ﹤0.01% | 3220 |
|
2022
Q3 | $119K | Hold |
22,201
| – | – | ﹤0.01% | 3210 |
|
2022
Q2 | $89K | Sell |
22,201
-110,707
| -83% | -$444K | ﹤0.01% | 3298 |
|
2022
Q1 | $591K | Buy |
132,908
+4,523
| +4% | +$20.1K | ﹤0.01% | 3050 |
|
2021
Q4 | $514K | Buy |
128,385
+3,699
| +3% | +$14.8K | ﹤0.01% | 3135 |
|
2021
Q3 | $1.1M | Sell |
124,686
-413
| -0.3% | -$3.63K | ﹤0.01% | 2841 |
|
2021
Q2 | $1.42M | Buy |
125,099
+106,972
| +590% | +$1.21M | ﹤0.01% | 2819 |
|
2021
Q1 | $216K | Hold |
18,127
| – | – | ﹤0.01% | 3304 |
|
2020
Q4 | $125K | Hold |
18,127
| – | – | ﹤0.01% | 3301 |
|
2020
Q3 | $135K | Buy |
+18,127
| New | +$135K | ﹤0.01% | 3228 |
|
2020
Q2 | – | Sell |
-52,683
| Closed | -$131K | – | 3320 |
|
2020
Q1 | $131K | Sell |
52,683
-4,964
| -9% | -$12.3K | ﹤0.01% | 3079 |
|
2019
Q4 | $335K | Buy |
57,647
+4,111
| +8% | +$23.9K | ﹤0.01% | 2951 |
|
2019
Q3 | $283K | Sell |
53,536
-8,000
| -13% | -$42.3K | ﹤0.01% | 2979 |
|
2019
Q2 | $370K | Buy |
61,536
+19,826
| +48% | +$119K | ﹤0.01% | 2950 |
|
2019
Q1 | $377K | Sell |
41,710
-5,100
| -11% | -$46.1K | ﹤0.01% | 2863 |
|
2018
Q4 | $389K | Buy |
46,810
+17,110
| +58% | +$142K | ﹤0.01% | 2847 |
|
2018
Q3 | $410K | Hold |
29,700
| – | – | ﹤0.01% | 2907 |
|
2018
Q2 | $237K | Buy |
+29,700
| New | +$237K | ﹤0.01% | 3039 |
|